Clinical trial
Randomized Controlled Trial of Killed Oral Cholera Vaccine in Kolkata
NCT00289224 · International Vaccine Institute, Other · Completed
Key facts
| NCT number | NCT00289224 |
|---|---|
| Title | Randomized Controlled Trial of Killed Oral Cholera Vaccine in Kolkata |
| Official title | A Randomized Controlled Trial of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Eastern Kolkata, West Bengal, India |
| Lead sponsor | International Vaccine Institute, Other |
| Collaborators | National Institute of Cholera and Enteric Diseases, India Shantha Biotechnics Limited Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diarrhea, Cholera, Vibrio Infections |
| Intervention type | Biological |
| Interventions | bivalent killed whole cell oral cholera vaccine, Placebo |
| Enrollment | 69,329 |
| Start date | Jul 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | May 1, 2013 |
| First posted | Feb 9, 2006 |
| Last update posted | Jul 31, 2014 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: